Search Results - "Sy, Marie‐Pierre"
-
1
Female genital mutilation and noninvasive cervical abnormalities and invasive cervical cancer in Senegal, West Africa: A retrospective study
Published in International journal of cancer (15-03-2019)“…Female genital mutilation or cutting (FGM/C) is a traditional practice that affects a significant portion of women in sub‐Saharan Africa, Egypt, areas of the…”
Get full text
Journal Article -
2
Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015
Published in PloS one (31-12-2018)“…Non-communicable diseases, including hypertension (HTN), are increasingly recognized as important causes of morbidity and mortality among people living with…”
Get full text
Journal Article -
3
Correction: Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015
Published in PloS one (07-02-2019)“…[This corrects the article DOI: 10.1371/journal.pone.0208635.]…”
Get full text
Journal Article -
4
Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance Among Women in Senegal, West Africa
Published in The Journal of infectious diseases (26-04-2023)“…Abstract Background Persistent infection with high-risk human papillomavirus (HPV) is associated with development of invasive cervical cancer. Methods…”
Get full text
Journal Article -
5
Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants
Published in The Journal of infectious diseases (15-05-2024)“…The activity of lenacapavir against human immunodeficiency virus type 1 (HIV-1) has been extensively evaluated in vitro, but comparable data for human…”
Get full text
Journal Article -
6
Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants
Published in Antimicrobial agents and chemotherapy (01-05-2019)“…We compared the activity of the integrase inhibitor bictegravir against HIV-1 and HIV-2 using a culture-based, single-cycle assay. Values of 50% effective…”
Get full text
Journal Article -
7
A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa
Published in Clinical infectious diseases (30-10-2018)“…Our trial of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate in antiretroviral therapy-naive…”
Get full text
Journal Article -
8
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa
Published in Clinical infectious diseases (01-02-2021)“…Programmatic treatment outcome data for people living with human immunodeficiency virus type 2 (HIV-2) in West Africa, where the virus is most prevalent, are…”
Get full text
Journal Article -
9
HIV-2 Drug Resistance Genotyping from Dried Blood Spots
Published in Journal of clinical microbiology (17-12-2020)“…The treatment of HIV-2 in resource-limited settings (RLS) is complicated by the limited availability of HIV-2-active antiretroviral drugs and inadequate access…”
Get full text
Journal Article -
10
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa
Published in Clinical infectious diseases (30-03-2020)“…This study summarizes 13 years’ experience following people with Human Immunodeficiency Virus Type 2 (HIV-2) receiving antiretroviral therapy (ART) in Senegal…”
Get full text
Journal Article -
11
Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors
Published in Journal of virology (15-01-2016)“…Protease is essential for retroviral replication, and protease inhibitors (PI) are important for treating HIV infection. HIV-2 exhibits intrinsic resistance to…”
Get full text
Journal Article -
12
The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1
Published in Antimicrobial agents and chemotherapy (01-12-2015)“…Treatment options for individuals infected with human immunodeficiency virus type 2 (HIV-2) are restricted by the intrinsic resistance of the virus to…”
Get full text
Journal Article -
13
In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
Published in Retrovirology (05-02-2015)“…Dolutegravir recently became the third integrase strand transfer inhibitor (INSTI) approved for use in HIV-1-infected individuals. In contrast to the extensive…”
Get full text
Journal Article -
14
Infection à VIH-2 au Sénégal: échecs virologiques et résistances aux antirétroviraux (ARV)
Published in The Pan African medical journal (18-07-2019)Get full text
Journal Article -
15
HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)
Published in The Pan African medical journal (2019)“…HIV-2, endemic in West Africa, has a natural resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) which makes it difficult to treat it in…”
Get full text
Journal Article -
16
Long-term experience and outcomes of programmatic antiretroviral therapy for HIV-2 infection in Senegal, West Africa
Published in Clinical infectious diseases (30-03-2020)“…Programmatic treatment outcome data for people living with HIV-2 in West Africa, where the virus is most prevalent, are scarce. HIV-2-infected adults…”
Get full text
Journal Article -
17
Infection à VIH-2 au Sénégal: échecs virologiques et résistances aux antirétroviraux (ARV)
Published in The Pan African medical journal (2019)“…IntroductionLe VIH-2, endémique en Afrique de l'Ouest, est naturellement résistant aux inhibiteurs non nucléosidiques de la rétro transcriptase (INNRTI), ce…”
Get full text
Journal Article